Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hyaluronic acid + sh-polypeptide-6 + sh-oligopeptide-1
- Development stage
- Unknown
- Lead developer
- C. Contrad Swiss
- Modality
- Peptides
- Administration
- Topical
01
Overview
Egyfil is a novel topical formulation developed by Contrad Swiss SA for the relief of musculoskeletal and myofascial pain, stiffness, and reduced mobility. The product is a combination of hyaluronic acid (sodium hyaluronate) and two recombinant human peptides: SH-Polypeptide-6 and SH-Oligopeptide-1. SH-Polypeptide-6 is a recombinant version of human Interleukin-10 (IL-10), which provides anti-inflammatory and pain-alleviating properties through Interleukin-10 receptor activation. SH-Oligopeptide-1 is a recombinant version of human Epidermal Growth Factor (EGF), which supports tissue repair and soothing. Hyaluronic acid serves as a structural lubricant and hydrating agent. Egyfil has been investigated in a prospective, pre-market interventional study (NCT05486897) to evaluate its efficacy and safety in patients with mild to moderate musculoskeletal pain.
- Brand names
- EgyfilEgyfil Pain Lotion
- Other names
- PAIN LOTION
02
Targets
IL10RA (Interleukin-10 Receptor)EGFR (Epidermal growth factor receptor)
Beyond the preview
Go deeper on hyaluronic acid + sh-polypeptide-6 + sh-oligopeptide-1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hyaluronic acid + sh-polypeptide-6 + sh-oligopeptide-1.